Cytokinetics EVP Executes Near‑100% Profit in 24 Hours – Insider Buying & Option Liquidations Raise Investor Curiosity
Malik Fady Ibraham’s recent Cytokinetics insider trades reveal a bullish buy‑sell‑option strategy, hinting at short‑term upside and risk‑hedging ahead of key milestones.
3 minutes to read









